Microsoft powerpoint - 6. treatment of infected pressure sores

Treatment of Infected Pressure Ulcers
Dr. Hasan Syed Ahmedullah
Clinical Fellow Infectious Disease
2. Pressure Ulcer Classification 3. Strength of Evidence 4. Strength of Recommendation 5. Assessment of high risk individuals •Bacteria are present on all skin surfaces •When the primary defense provided by intact skin is lost, bacteria will reside on the wound surface •When the bacteria (by numbers or virulence) cause damage to the body, •An impaired host has a reduced ability to combat bacteria •The number of bacteria and their effect on the host can be categorized as contamination, colonization, or infection International NPUAP – EPUAP Pressure Ulcer Classification •Stage 1 – Non blanchable redness of intact skin •Stage 2 – Partial thickness skin loss or blister •Stage 3 – Full thickness skin loss (fat visible) •Stage 4 – Full thickness tissue loss (muscle/bone visible) Strength of Recommendations 2. Strong positive recommendation, definitely do it 1. weak positive recommendation, probably do it 0. no specific recommendation -1. weak negative recommendation, probably don't do it -2. strong negative recommendation, definitely don't do it Infection is not common in Stage I or II ulcers, and assessment of infection should focus on Stage III and IV ulcers Infection may spread beyond the pressure ulcer, resulting in serious systemic infections such as cellulitis, fasciitis, osteomyelitis, SIRS or sepsis To avoid these serious consequences, the professional should focus on identification of high-risk individuals, prevention, early detection, and prompt, effective treatment of pressure ulcer infection.
System Consideration Follow local infection-control policies to prevent self-contamination and cross-contamination in individuals with pressure ulcers. (Strength of Evidence = C) (Strength of Recommendation = 1) Assessment of High-Risk Individuals and Pressure Ulcers 1. Have a high index of suspicion for the likelihood of infection in pressure ulcers that have necrotic tissue or a foreign body present been present for a long period of time are large in size or deep are likely to be repetitively contaminated (e.g., near the anus). (Strength of Evidence = C) (Strength of Recommendation = 1) Have a high index of suspicion for local wound infection in individuals with diabetes mellitus protein-calorie under nutrition hypoxia or poor tissue perfusion autoimmune disease immunosuppression. (Strength of Evidence = B) (Strength of Recommendation = 1) 3.Have a high index of suspicion for local infection in pressure ulcers when no signs of healing for 2 weeks friable granulation tissue, foul odor, increased pain in the ulcer Increased heat in the tissue around the ulcer increased drainage from the wound or ominous change in the nature of the wound drainage (e.g., new onset of bloody drainage, purulent drainage) Increased necrotic tissue in the wound bed, pocketing, or bridging is present. (Strength of Evidence = B) (Strength of Recommendation = 1) Have a high index of suspicion of biofilm in a pressure has been present for more than 4 weeks; lacks signs of any healing in the previous 2 weeks; displays clinical signs and symptoms of does not respond to antimicrobial therapy. (Strength of Evidence = C) (Strength of Recommendation = 1) Consider a diagnosis of spreading acute infection if the pressure ulcer has signs of acute infection, such as • erythema extending from the ulcer edge • new or increasing pain • purulent drainage The acutely infected ulcer may also be increasing in size or have crepitus, fluctuance, or discoloration in the surrounding skin The individual may also have systemic signs of infection such asfever, malaise, and lymph node enlargement Elderly individuals may develop confusion/delirium and anorexia.
(Strength of Evidence = C) (Strength of Recommendation = 2) Determine the bacterial bio burden of the pressure ulcer by tissue biopsy or quantitative swab technique. (Strength of Evidence = B) (Strength of Recommendation = 1) The gold standard method for examining microbial load is quantitative culture of viable wound tissue Surface swabs will only reveal the colonizing organism, and may not reflect deeper tissue infection Apply sufficient pressure to swab to cause tissue fluid to be expressed.
Use sterile technique to break tip of swab into a collection device designed for quantitative cultures Consider a diagnosis of pressure ulcer infection if the culture results indicate bacterial bioburden of > 105 CFU/g of tissue and/or thepresence of beta hemolytic streptococci. (Strength of Evidence = B) (Strength of Recommendation = 1) Necrotic tissue and slough promote bacterial growth Cleansing removes loose debris and planktonic (free-floating) bacteria Debridement is often required to remove adherent slough and eschar, as well as biofilms Once removed, biofilms tend to redevelop. Antimicrobials may help slow the rate of biofilm redevelopment Additional research is required to elucidate best practice for diagnosing and managing biofilms in pressure ulcers and other chronic wounds 1. Optimize the host response.(Strength of Evidence = C) (Strength of Recommendation = 2) a. Nutrition status b. Glycemic control c. Arterial blood flow d. Reduce immunosuppression 2. Prevent contamination of the pressure ulcer. (Strength of Evidence = C) (Strength of Recommendation = 2) 3. Reduce the bacterial load in the pressure ulcer (Strength of Evidence = C) (Strength of Recommendation = 1) 4. Consider the use of tissue appropriate strength, non-toxic topical antiseptics for a limited time period to control bacterial bioburden. (Strength of Evidence = C) (Strength of Recommendation = 1) •Hydrogen peroxide is highly toxic to tissues even at low concentrations and is not preferred •It should be totally avoided in cavity wounds due to the risk of surgical emphysema and gas embolus Iodine products should be avoided in patients with impaired renal failure, history of thyroid disorders or known iodine sensitivity Sodium hypochlorite (Dakin's solution) is cytotoxic at all concentrations and should be used with caution, at concentrations no greater than 0.025%, for short periods only when no other appropriate option is available There is a risk of acidosis when acetic acid is used for extended periods over large wound surface areas Antiseptics commonly used in wounds include: iodine compounds (povidone iodine and slow-release cadexomer iodine) silver compounds (including silver sulfadiazine) • polyhexanide and betaine (PHMB) sodium hypochlorite 5. Consider the use of topical antiseptics in conjunction with maintenance debridement to control and eradicate suspected biofilm in wounds with delayed healing. (Strength of Evidence = C)(Strength of Recommendation = 1) 6. Consider the use of topical antiseptics for pressure ulcers that are not expected to heal and are critically colonized. (Strength of Evidence = C) (Strength of Recommendation = 1) 7.Consider use of silver sulfadiazine in heavily contaminated or infected pressure ulcers until definitive debridement is accomplished. (Strength of Evidence = C) (Strength of Recommendation = 0) •Silver may have toxic properties, especially to keratinocytes and fibroblasts; the extent of the toxicities is not fully described 8. Consider the use of medical-grade honey in heavily contaminated or infected pressure ulcers until definitive debridement is accomplished. (Strength of Evidence = C) (Strength of Recommendation = 0) • Before applying a honey dressing, ensure the individual is not allergic to honey • Individuals who have bee or bee stings allergies are usually able to use properly irradiated honey products 9. Limit the use of topical antibiotics on infected pressure ulcers, except in special situations, where the benefit outweighs the risks. (Strength of Evidence = C) (Strength of Recommendation = 1) 10. Use systemic antibiotics for individuals with clinical evidence of systemic infection, such as positive blood cultures, cellulitis, fasciitis, osteomyelitis, SIRS, or sepsis, if consistent with the individual's goals. (Strength of Evidence = C) (Strength of Recommendation = 1) 11. Drain local abscesses. (Strength of Evidence = C) (Strength of Recommendation = 2) 10. Evaluate the individual for osteomyelitis if exposed bone is present, the bone feels rough or soft, or the ulcer has failed to heal with prior therapy. (Strength of Evidence = C) (Strength of Recommendation = 1) In general, topical antibiotics are not recommended for pressure ulcers Reasons for this include • inadequate penetration for deep skin infections • development of antibiotic resistance • hypersensitivity reactions • systemic absorption when applied to large wounds, and local irritant effects, all of which can lead to further delay in wound healing However, short courses of silver sulfadiazine, topical antibiotic solutions, or topical metronidazole can be useful in certain circumstances — • on wounds that have been debrided and cleansed, yet still have a bacterial bioburden of > 105 CFU/g of tissue • and/or the presence of beta hemolytic streptococci Topical metronidazole might be used for the treatment of malodorin fungating wounds or wounds with anaerobic infection 1. Cleanse the pressure ulcer and surrounding skin at the time of each dressing change. (Strength of Evidence = C) (Strength of Recommendation = 1) • Clean pressure ulcers with normal saline or potable water (i.e., water suitable for drinking). (Strength of Evidence = C) (Strength of Recommendation = 1) • Consider using an aseptic technique when the individual, the wound or the wound healing environment is compromised. (Strength of Evidence = C) (Strength of Recommendation = 1) Consider using cleansing solutions with surfactants and/or antimicrobials to clean pressure ulcers with debris, confirmed infection, suspected infection, or suspected high levels of bacterial colonization. (Strength of Evidence = C) (Strength of Recommendation = 1) Cleanse surrounding skin. (Strength of Evidence = B) (Strength of Recommendation = 2) Cleanse pressure ulcers with sinus tracts/tunneling/undermining with caution. (Strength of Evidence = C) (Strength of Recommendation = 1) Cleanse the pressure ulcer using an irrigation solution, and apply sufficient pressure to cleanse the wound without damaging tissueor driving bacteria into the wound. (Strength of Evidence = C)(Strength of Recommendation = 2) • Generally, irrigation pressure between 4 and 15 PSI should be adequate to clean the surface of the pressure ulcer without causing trauma to the wound bed.
Contain and properly dispose of used irrigation solution to reduce cross-contamination. (Strength of Evidence = C) (Strength of Recommendation = 2) Debride devitalized tissue within the wound bed or edge of pressure ulcers when appropriate to the individual's condition and consistent with goals of care. (Strength of Evidence = C) (Strength of Recommendation = 2) Debridement should only be performed when there is adequate perfusion to the wound 2. Debride the wound bed when the presence of biofilm is suspected or confirmed. (Strength of Evidence = C) (Strength of Recommendation = 1) When a wound has delayed healing (4 weeks or more) and fails to respond to standard wound care and/or antimicrobial therapy, have a high index of suspicion of the presence of biofilm 3. Select the debridement method(s) most appropriate to: • the individual's condition goals of care • ulcer/periulcer status • type, quantity, and location of necrotic tissue • professional accessibility/capability.(Strength of Evidence = C) (Strength of Recommendation = 2) Potential methods include • sharp/surgical techniques • enzymatic debridement • mechanical debridement • biosurgical debridement (maggot therapy) 4. Perform surgical debridement in the presence of advancing cellulitis, crepitus, fluctuance, and/or sepsis secondary to ulcer-related infection. (Strength of Evidence = C) (Strength of Recommendation = 1) 5. Sharp/surgical debridement must be performed by specially trained, competent, qualified, and licensed healthcare professionals consistent with local legal and regulatory statutes. (Strength of Evidence = C) (Strength of Recommendation = 2) 6. Use sterile instruments to sharply/surgically debride. (Strength of Evidence = C) (Strength of Recommendation = 2) 7. Use sharp debridement with caution in the presence of • immune incompetence • compromised vascular supply to the limb • lack of antibacterial coverage in systemic sepsis • Relative contraindications include anticoagulant therapy and bleeding disorders. (Strength of Evidence = C) (Strength of Recommendation = 1) Refer individuals with Stage III or IV pressure ulcers with undermining, tunneling, sinus tracts, and/or extensive necrotic tissue that cannot be easily removed by other debridement methods for surgical evaluation as is appropriate with the individual's condition and goals of care. (Strength of Evidence = C)(Strength of Recommendation = 2) 9. Manage pain associated with debridement. (Strength of Evidence = C) (Strength of Recommendation = 2) 10. Perform a thorough vascular assessment prior to debridement of lower extremity pressure ulcers (e.g., rule out arterial insufficiency). (Strength of Evidence = C) (Strength of Recommendation = 2) 11. Do not debride stable, hard, dry eschar in ischemic limbs. (Strength of Evidence = C) (Strength of Recommendation = 1) Assess the wound daily for signs of • fluctuance, crepitance, and/or malodor (i.e., signs of infection). (Strength of Evidence = C) (Strength of Recommendation = 2) Consult a vascular surgeon urgently in the presence of the abovesymptoms. (Strength of Evidence = C) (Strength of Recommendation = 1) Debride urgently in the presence of the above symptoms if consistent with the individual's wishes and overall goals of care. (Strength of Evidence = C) (Strength of Recommendation = 1) 12. Perform maintenance debridement on a chronic pressure ulcer until the wound bed is covered with granulation tissue and free of necrotic tissue. (Strength of Evidence = C) (Strength of Recommendation = 1) National Pressure Ulcer Advisory Panel (NPUAP), European Pressure Ulcer Advisory Panel (EPUAP) and Pan Pacific Pressure Injury Alliance (PPPIA). Prevention and Treatment of Pressure Ulcers: Quick Reference Guide. Emily Haesler (Ed.). Cambridge Media: Perth, Australia; 2014.

Thank you

Source: http://pus.hamad.qa/en/images/infected_pressure_sores_final.pdf